Researchers have screened over 2,000 compounds to discover that rocaglates effectively combat C. auris, offering a potential new treatment.
List view / Grid view
Filter the results
A study has shown that plasmids use type IV CRISPR-Cas against competing plasmids, leading the researchers to suggest the method as a novel way to tackle multi-drug resistant bacteria.
Researchers have found that using antibiotics in combination with cannabidiol (CBD) enhanced their effect against Staphylococcus aureus bacteria.
Researchers have shown that CRISPR-Cas3 can successfully attack C. difficile in vitro and in mice, by causing DNA damage to the pathogen.
Researchers have developed a new combination of compounds called AB569 which has demonstrated success at fighting deadly pathgoens like Pseudomonas aeruginosa.
Flexible and intuitive operation of a wide range of biological processes with the SciVario® twin bioreactor control system.
Researchers have uncovered new antibiotics which prevent bacteria from multiplying, offering a strategy to fight infections.
Researchers have found that, in rainbow trout models, phages on mucosal surfaces infect pathogenic bacteria, providing protection.
A compound that has antimicrobial properties has been found by researchers, which could be used to combat drug-resistant infections.
A team of researchers has uncovered the structure of a T-box regulatory mechanism in bacteria, which could aid in the development of novel antibiotics.
A study has revealed an enzyme in bacteria that produces a molecule which is toxic to other bacteria and shows promise as an antibiotic substitute.
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
Method IDs which target therapies, inadequately on their own, can be paired up to kill non-responsive cancers...